Adherence, Quality of Life, Cost Effectiveness, and the Role of the Pharmacist

Comprehensive Hypertension

Volumn , Issue , 2007, Pages 1119-1127

  Carter, Barry L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68149166846     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03961-1.50095-7     Document Type: Chapter

References (68)

1. AV Chobanian, GL Bakris, HR Black, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6), 1206-1252.
2. RH Grimm Jr, KL Margolis, VV Papademetriou, et al. (2001) Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 37(1), 19-27.
3. L Hansson, A Zanchetti, SG Carruthers, et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351(9118), 1755-1762.
4. HR Black, WJ Elliott, JD Neaton, et al. (2001) Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension 37(1), 12-18.
5. BL Carter, ED Frohlich, WJ Elliott, et al. (1994) Selected factors that influence responses to antihypertensives: Choosing therapy for the uncomplicated patient. Arch Fam Med 3(6), 528-536.
6. DJ Hyman and VN Pavlik (2001) Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345(7), 479-486.
7. DR Berlowitz, AS Ash, EC Hickey, et al. (1998) Inadequate management of blood pressure in a hypertensive population. N Engl I Med 339(27), 1957-1963.
8. SA Oliveria, P Lapuerta, BD McCarthy, et al. (2002) Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 162(4), 413-420.
9. JP Garg, WJ Elliott, AC Folker, et al. (2005) Resistant hypertension revisited. Am I Hypertens 18 619-626.
10. JJ Caro, M Salas, JL Speckman, et al. (1999) Persistence with treatment for hypertension in actual practice. CMAj 160(1), 31-37.
11. E Degli Esposti, A Sturani, M Di Martino, et al. (2002) Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 16(6), 439-444.
12. L Degli Esposti, E Degli Esposti, G Valpiani, et al. (2002) A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 24(8), 1347-1357. discussion 1346
13. JM Flack, SV Novikov and CM Ferrario (1996) Benefits of adherence to antihypertensive drug therapy. Eur Heart J 17(Suppl A), 16-20.
14. MA Espeland, PK Whelton, JB Kostis, et al. (1999) Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med 8(3), 228-236.
15. RE Grymonpre, CD Didur, PR Montgomery and DS Sitar (1998) Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 32(7/8), 749-754.
16. DE Morisky, LW Green and DM Levine (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24(1), 67-74.
17. BL Svarstad, BA Chewning, BL Sleath and C Claesson (1999) The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns 37(2), 113-124.
18. G Ogedegbe, CA Mancuso, JP Allegrante and ME Charlson (2003) Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol 56(6), 520-529.
19. MT Kim, MN Hill, LR Bone and DM Levine (2000) Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 15(3), 90-96.
20. JDK Dunbar-Jacob and J Dunning (1991) Compliance with antihypertensive regimen: A review of the research in the 1980s. Ann Behav Med 13 31-39.
21. SJ Billups, DC Malone and BL Carter (2000) The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 20(8), 941-949.
22. M Monane, RL Bohn, JH Gurwitz, et al. (1997) The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly. Am J Hypertens 10(7 Pt 1), 697-704.
23. PW Choo, CS Rand, TS Inui, et al. (1999) Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37(9), 846-857.
24. JY Lee, JW Kusek, PG Greene, et al. (1996) Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 9(8), 719-725.
25. IS Ockene and JK Ockene (1996) Barriers to lifestyle change, and the need to develop an integrated approach to prevention. Cardiol Clin 14(1), 159-169.
26. G Ogedegbe, M Harrison, L Robbins, et al. (2004) Reasons patients do or do not take their blood pressure medications. Ethn Dis 14(1), 158.
27. G Ogedegbe, M Harrison, L Robbins, et al. (2004) Barriers and facilitators of medication adherence in hypertensive African Americans: A qualitative study. Ethn Dis 14(1), 3-12.
28. L Vaur, B Vaisse, N Genes, et al. (1999) Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. Am J Hypertens (4 Pt 1), 374-380. 12
29. MT Kim, HR Han, MN Hill, et al. (2003) Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med 26(1), 24-31.
30. R Nuesch, K Schroeder, T Dieterle, et al. (2001) Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: A prospective case-control study. BMJ 323(7305), 142-146.
31. EL Knight, RL Bohn, PS Wang, et al. (2001) Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 38(4), 809-814.
32. K Schroeder, T Fahey and S Ebrahim (2004) How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 164(7), 722-732.
33. NH Miller, M Hill, T Kottke and IS Ockene (1997) The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals. Circulation 95(4), 1085-1090.
34. J Bernardini (2004) Ethical issues of compliance/adherence in the treatment of hypertension. Adv Chronic Kidney Dis 11(2), 222-227.
35. JM Flack, C Yunis, J Preisser, et al. (2000) The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: The Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group. Arch Intern Med 160(12), 1842-1847.
36. JS Cohen (2001) Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference. Arch Intern Med 161(6), 880-885.
37. BL Carter, A Zillich, et al. (2004) Management of essential hypertension. GT Schumock, DM Brundage, KH Chessman (Eds) The Pharmacotherapy Self-Assessment Program, Fifth Edition Kansas City: The American College of Clinical Pharmacy; 129-163.
38. SA Eisen, DK Miller, RS Woodward, et al. (1990) The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150(9), 1881-1884.
39. MD Murray, JA Birt, AK Manatunga and JC Darnell (1993) Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 27(5), 616-621.
40. PS Wang, RL Bohn, E Knight, et al. (2002) Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17(7), 504-511.
41. SR Erickson, BC Williams and LD Gruppen (2001) Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens 15(8), 539-548.
42. JD Neaton, RH Grimm Jr, RJ Prineas, et al. (1993) Treatment of Mild Hypertension Study: Final results. Treatment of Mild Hypertension Study Research Group. JAMA 270(6), 713-724.
43. MH Alderman, S Madhavan and H Cohen (1996) Antihypertensive Drug Therapy: The effect of JNC criteria on prescribing patterns and patient status through the first year. Am J Hypertens 9(5), 413-418.
44. S Benson, K Vance-Bryan and J Raddatz (2000) Time to patient discontinuation of antihypertensive drugs in different classes. Am J Health Syst Pharm 57(1), 51-54.
45. SD Ross, KS Akhras, S Zhang, et al. (2001) Discontinuation of antihypertensive drugs due to adverse events: A systematic review and meta-analysis. Pharmacotherapy 21(8), 940-953.
46. BJ Materson, DJ Reda, WC Cushman, et al. (1993) Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 328(13), 914-921.
47. I Cote, K Farris and D Feeny (2003) Is adherence to drug treatment correlated with health-related quality of life? Qual Life Res 12(6), 621-633.
48. J Kennedy, J Coyne and D Sclar (2004) Drug affordability and prescription noncompliance in the United States: 1997–2002. Clin Ther 26(4), 607-614.
49. MA Raji, YF Kuo, JA Salazar, et al. (2004) Ethnic differences in antihypertensive medication use in the elderly. Ann Pharmacother 38(2), 209-214.
50. MA Fischer and J Avorn (2004) Economic implications of evidence-based prescribing for hypertension: Can better care cost less? JAMA 291(15), 1850-1856.
51. BL Carter, ME Ernst and JD Cohen (2004) Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability. Hypertension 43(1), 4-9.
52. BL Carter, AJ Zillich and WJ Elliott (2003) How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens 5(1), 31-37.
53. RW Hammond, AH Schwartz, MJ Campbell, et al. (2003) Collaborative drug therapy management by pharmacists 2003. Pharmacotherapy 23(9), 1210-1225.
54. BL Carter, DJ Barnette, E Chrischilles, et al. (1997) Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 17(6), 1274-1285.
55. JJ Park, P Kelly, BL Carter and PP Burgess (1996) Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash) 36(7), 443-451. NS
56. JM McKenney, JM Slining, HR Henderson, et al. (1973) The effect of clinical pharmacy services on patients with essential hypertension. Circulation 48(5), 1104-1111.
57. JE Borenstein, G Graber, E Saltiel, et al. (2003) Physician-pharmacist comanagement of hypertension: A randomized, comparative trial. Pharmacotherapy 23(2), 209-216.
58. PE Bogden, RD Abbott, P Williamson, et al. (1998) Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 13(11), 740-745.
59. R Monson, CA Bond and A Schuna (1981) Role of the clinical pharmacist in improving drug therapy: Clinical pharmacists in outpatient therapy. Arch Intern Med 141(11), 1441-1444.
60. CA Bond and R Monson (1984) Sustained improvement in drug documentation, compliance, and disease control: A four-year analysis of an ambulatory care model. Arch Intern Med 144(6), 1159-1162.
61. SR Erickson, R Slaughter and H Halapy (1997) Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 17(1), 140-147.
62. WF McGhan, GL Stimmel, TG Hall and TM Gilman (1983) A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 21(4), 435-444.
63. DW Hawkins, FP Fiedler, HL Douglas and RC Eschbach (1979) Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 36(10), 1321-1325.
64. BM Mehos, JJ Saseen and EJ MacLaughlin (2000) Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 20(11), 1384-1389.
65. MD Schoen, RJ DiDomenico, SE Connor, et al. (2001) Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy 21(12), 1455-1463.
66. Anon. The State of Health Care Quality 2004. The National Committee for Quality Assurance, Washington, D.C. http://www.ncqa.org. Accessed November 12, 2004.
67. S Alsuwaidan, DC Malone, SJ Billups and BL Carter (1998) Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers. IMPROVE investigators. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Am J Health Syst Pharm 55(1), 68-72.
68. BL Carter (2001) Management of essential hypertension. K Bertch, T Dunsworth, S Fagan, et al., (Eds) The Pharmacotherapy Self-Assessment Program, Fourth Edition Kansas City: The American College of Clinical Pharmacy 1-39.